Teva Said to Be Close to Buying Generic Drug Unit of Allergan by MICHAEL J. de la MERCED

By MICHAEL J. de la MERCED

A successful purchase, pegged for about $45 billion, would be the latest deal in healthcare, a spree that has ranged from drug makers to insurance providers.

Published: July 27, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1S2q5vN

from WordPress http://ift.tt/1IvXx9H
via Hadi Aboukhater